Axatilimab, sold under the brand name Niktimvo, is a monoclonal antibody used for the treatment of chronic graft-versus-host disease. It is a blocker of...
7 KB (391 words) - 20:04, 29 May 2025
chronic GvHD after failure of one or more other systemic treatments. Axatilimab (Niktimvo) was approved for medical use in the United States in August...
39 KB (4,484 words) - 21:00, 29 May 2025
avosentan (INN) avotermin (INN) avridine (INN) Avzivi Awiqli axamozide (INN) axatilimab (INN) Axberi Axberi HP Axert axicabtagene ciloleucel (USAN, INN) Axid...
11 KB (533 words) - 21:48, 16 May 2025
Siltuximab Ublituximab Zolbetuximab Humanized Abituzumab§ Alemtuzumab Axatilimab Belantamab mafodotin Bevacizumab Bivatuzumab mertansine§ Brontictuzumab§...
3 KB (129 words) - 17:07, 28 May 2025
the newborn[citation needed] Avelumab Bavencio mab human PD-L1 Y cancer Axatilimab Niktimvo mab humanized CSF1R Y chronic graft-versus-host disease Azintuxizumab...
142 KB (4,345 words) - 21:22, 29 May 2025
ozogamicin) Other Amivantamab Atezolizumab (+hyaluronidase) Avelumab Axatilimab Belantamab mafodotin Bermekimab Blinatumomab Cemiplimab Cosibelimab Daratumumab...
12 KB (829 words) - 20:43, 29 May 2025
ozogamicin) Other Amivantamab Atezolizumab (+hyaluronidase) Avelumab Axatilimab Belantamab mafodotin Bermekimab Blinatumomab Cemiplimab Cosibelimab Daratumumab...
12 KB (731 words) - 21:34, 29 May 2025
Siltuximab Ublituximab Zolbetuximab Humanized Abituzumab§ Alemtuzumab Axatilimab Belantamab mafodotin Bevacizumab Bivatuzumab mertansine§ Brontictuzumab§...
5 KB (368 words) - 15:29, 21 August 2024
Siltuximab Ublituximab Zolbetuximab Humanized Abituzumab§ Alemtuzumab Axatilimab Belantamab mafodotin Bevacizumab Bivatuzumab mertansine§ Brontictuzumab§...
4 KB (241 words) - 13:42, 14 July 2024